Gulbu Uzel Selected Research

Dysgammaglobulinemia

1/2020	Defective glycosylation and multisystem abnormalities characterize the primary immunodeficiency XMEN disease.
2/2015	Identification of a novel mutation in MAGT1 and progressive multifocal leucoencephalopathy in a 58-year-old man with XMEN disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gulbu Uzel Research Topics

Disease

14	Infections 01/2022 - 10/2003
13	Neoplasms (Cancer) 01/2022 - 11/2003
8	Chronic Granulomatous Disease 01/2021 - 12/2010
7	Epstein-Barr Virus Infections 01/2020 - 04/2013
6	Lymphadenopathy 10/2021 - 04/2013
5	Lymphopenia (Lymphocytopenia) 01/2022 - 07/2011
5	Virus Diseases (Viral Diseases) 10/2021 - 11/2009
4	Reinfection 01/2021 - 12/2010
4	Primary Immunodeficiency Diseases 01/2020 - 03/2013
4	Job Syndrome (Hyper-IgE Syndrome) 06/2014 - 10/2007
3	Cytopenia 01/2020 - 02/2010
3	Ectodermal Dysplasia (Aplasia Cutis Congenita) 01/2017 - 09/2002
3	Colitis 01/2017 - 12/2010
3	Communicable Diseases (Infectious Diseases) 12/2014 - 08/2013
3	Inflammation (Inflammations) 04/2012 - 11/2003
2	Cryptosporidiosis 01/2021 - 05/2012
2	Common Variable Immunodeficiency 01/2021 - 09/2010
2	Dysgammaglobulinemia 01/2020 - 02/2015
2	Immune System Diseases (Immune Disorders) 01/2019 - 09/2002
2	Abscess 01/2018 - 08/2012
2	Liver Abscess 01/2018 - 03/2012
2	Respiratory Tract Infections (Respiratory Tract Infection) 01/2018 - 01/2018
2	Leukocyte adhesion deficiency type 1 01/2017 - 03/2014
2	Mycoses (Diseases, Fungus) 01/2017 - 03/2016
2	Chronic Mucocutaneous Candidiasis 04/2016 - 06/2013
2	Histoplasmosis 01/2016 - 06/2013
2	Starvation 07/2015 - 07/2015
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 07/2015 - 11/2010
2	Periodontitis 03/2015 - 03/2014
2	Lymphoma (Lymphomas) 02/2015 - 04/2014
2	Lymphedema (Milroy Disease) 02/2014 - 09/2002
2	Coccidioidomycosis 06/2013 - 02/2011
2	Pneumonia (Pneumonitis) 09/2011 - 10/2007
2	Eosinophilia 11/2009 - 03/2008
1	Interstitial Lung Diseases (Interstitial Lung Disease) 07/2022
1	Adenoma (Adenomas) 01/2022
1	Activated PI3K-delta Syndrome 01/2022
1	Cushing Syndrome 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Eczema 01/2022
1	Viremia 10/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Hyperplasia 01/2021

Drug/Important Bio-Agent (IBA)

6	MagnesiumIBA 01/2020 - 07/2011
5	AutoantibodiesIBA 08/2016 - 02/2010
4	Immunoglobulin E (IgE)IBA 01/2022 - 10/2007
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2010
4	Immunoglobulin M (IgM)IBA 01/2018 - 09/2002
4	AntibodiesIBA 11/2015 - 01/2011
4	CytokinesIBA 06/2014 - 11/2003
3	NF-kappa B (NF-kB)IBA 07/2022 - 03/2008
3	Sirolimus (Rapamycin)FDA Link 07/2022 - 01/2014
3	interleukin-21 (interleukin 21)IBA 01/2022 - 08/2013
3	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2021 - 12/2010
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 08/2018
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 09/2011
3	NADP (NADPH)IBA 01/2018 - 04/2015
3	Interleukin-12 (IL 12)IBA 01/2017 - 09/2002
3	STAT1 Transcription FactorIBA 04/2016 - 09/2002
3	Immunoglobulin G (IgG)IBA 01/2011 - 03/2008
2	I-kappa B KinaseIBA 07/2022 - 09/2002
2	Phosphotransferases (Kinase)IBA 07/2022 - 03/2008
2	Interleukin-21 ReceptorsIBA 01/2021 - 03/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021 - 12/2010
2	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019 - 01/2018
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2018 - 11/2017
2	VaccinesIBA 01/2018 - 03/2013
2	Interleukin-23 (Interleukin 23)IBA 01/2017 - 03/2014
2	Oxidoreductases (Dehydrogenase)IBA 03/2016 - 04/2015
2	Messenger RNA (mRNA)IBA 07/2015 - 07/2015
2	IntegrinsIBA 03/2014 - 01/2008
2	GATA2 Transcription FactorIBA 02/2014 - 04/2013
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 08/2013 - 11/2011
2	Immunoglobulins (Immunoglobulin)IBA 04/2013 - 02/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2012 - 05/2010
2	Interleukin-12 Receptors (Interleukin 12 Receptor)IBA 02/2011 - 09/2002
2	Immunoglobulin A (IgA)IBA 01/2011 - 03/2008
2	AntigensIBA 01/2011 - 11/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010 - 11/2003
2	Interferon-gamma (Interferon, gamma)IBA 10/2003 - 09/2002
1	IgG Receptors (Fc gamma RI)IBA 07/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2022
1	Leukocyte Common Antigens (CD45 Antigen)IBA 07/2022
1	NF-kappaB-Inducing KinaseIBA 07/2022
1	L-SelectinIBA 07/2022
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 07/2022
1	Basic Helix-Loop-Helix Transcription FactorsIBA 07/2022
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 07/2022
1	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 07/2022
1	Epstein-Barr Virus Nuclear AntigensIBA 07/2022
1	Complement C3d (Complement 3d)IBA 07/2022
1	GlucocorticoidsIBA 01/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022
1	ChromatinIBA 10/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 10/2021
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2021

Therapy/Procedure

9	Therapeutics 01/2022 - 02/2006
3	Transplantation 01/2020 - 01/2017
2	Cell Transplantation 01/2022 - 01/2020
2	Immunotherapy 01/2018 - 01/2016